2005
DOI: 10.1016/j.ajo.2004.12.038
|View full text |Cite
|
Sign up to set email alerts
|

Low prevalence of MYOC mutations in UK primary open-angle glaucoma patients limits the utility of genetic testing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2006
2006
2009
2009

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 0 publications
0
8
0
Order By: Relevance
“…This genetic form of glaucoma is typically associated with high intraocular pressures and frequently requires surgical intervention for disease control. In adult POAG populations, the prevalence of myocilin mutations in POAG cases varies between 3 and 5% making it the most common form of inherited glaucoma currently known (Aldred et al, 2004;Alward et al, 1998;Baird et al, 2005b;Chakrabarti et al, 2005;Challa et al, 2002;Fingert et al, 1999;Hulsman et al, 2002;Jansson et al, 2003;Libby et al, 2005;Mukhopadhyay et al, 2002;Shimizu et al, 2000;Sripriya et al, 2004).…”
Section: Myocilinmentioning
confidence: 99%
“…This genetic form of glaucoma is typically associated with high intraocular pressures and frequently requires surgical intervention for disease control. In adult POAG populations, the prevalence of myocilin mutations in POAG cases varies between 3 and 5% making it the most common form of inherited glaucoma currently known (Aldred et al, 2004;Alward et al, 1998;Baird et al, 2005b;Chakrabarti et al, 2005;Challa et al, 2002;Fingert et al, 1999;Hulsman et al, 2002;Jansson et al, 2003;Libby et al, 2005;Mukhopadhyay et al, 2002;Shimizu et al, 2000;Sripriya et al, 2004).…”
Section: Myocilinmentioning
confidence: 99%
“…Currently it is not cost‐effective to conduct population‐based screening for MYOC mutations which have a prevalence of approximately 4% in adult onset POAG and over 10% in JOAG 61,71 . However, the efficacy for genetic screening will increase when conducting comprehensive combined screen of many POAG genes and as the cost of genetic tests decreases markedly because of technological advances.…”
Section: Myocilin‐related Glaucomamentioning
confidence: 99%
“…However, a number of other genes remain to be identified. [28][29][30][31] Although population-based screening is not currently costeffective, 32 it is possible to perform cascade screening, where the offspring and siblings of index mutation-carrying patients are screened for the mutation. We have recently demonstrated that genetic testing in "myocilin glaucoma" is perceived to be appropriate and desirable by both patients and their families.…”
Section: Commentmentioning
confidence: 99%